Trodelvy 180 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9DN8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,201
Award facts
- Contract value 100% obligated
- $20,201.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On November 28, 2025, the Defense Logistics Agency awarded a delivery order valued at $20,201.40 to AmerisourceBergen Drug Corp for the supply of Trodelvy 180 mg vials. This firm fixed-price delivery order, issued without a set-aside designation, is scheduled for completion by December 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trodelvy (sacituzumab govitecan) is a targeted cancer therapy used in the treatment of certain breast cancers and other malignancies, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support military and veteran healthcare needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Troop Support Medical division, designated SPE2DX and valued at $999,999,999.00 through December 2026. As the prime vendor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's substantial federal contract portfolio demonstrates its critical role in the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F9DN8?
SPE2DR26F9DN8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F9DN8 worth?
The government has obligated $20,201 on SPE2DR26F9DN8.
Is contract SPE2DR26F9DN8 an order under another contract?
Yes. SPE2DR26F9DN8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9DN8 competed?
The extent of competition for SPE2DR26F9DN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award